Skip to main content
OpenTrials
Completed

NCT Number: NCT02626195

Preoperative Nutritional Support in Malnutritional Cancer Patients

Malnutrition patients are known to have more postoperative complications and mortality. And most of hepatobiliary-pancreatic cancer surgeries accompany high postoperative morbidity and mortality rate. Therefore for the malnourished patients anticipating major surgery, preoperative nutritional support is recommended according to the ASPEN (American society of parenteral and enteral nutrition) and ESPEN (European society of parenteral and enteral nutrition) guideline. However there is no prospective trial to prove the clinical impact of preoperative nutritional support for malnourished patients.

The purpose of this study is to evaluate the clinical impact of preoperative nutritional support for malnourished cancer patients anticipating HBP surgery. Primary objective is to compare the complication rate and secondary object is to compare the quality of life, hospital stay and cost.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Cancer Center

Goyang-si, Gyeonggi-do, 410-769, South Korea

About this study

This is single arm study with historical comparison. The historical control group did not receiving nutritional support. In previous results show that about 25% complication rates. Complication rates are expected in the group receiving nutritional support is less than 10 % ( previous studies (NCCNCS-11-460)).

For support group, preoperative nutritional support is given for 5 or more days preoperatively by nutritional support program. Nutritional support program is briefly described below.

Interval: 5-10 days Contents: admission is required

  • Calories: 30-35Kg, via enteral or parenteral
  • Protein: 1.2-1.5g/Kg
  • Lipid : 1-1.5g/Kg
  • Mineral and vitamins supply
  • Blood glucose control
  • Daily monitoring by dietician and specialized nurse

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects in anticipating major surgery of hepatobiliary pancreatic cancer
  • Patients diagnosed with malnutrition (at least more than one)
  • PG-SGA B or C
  • Weight loss >10% within 6 month
  • BMI <18.5
  • Serum Albumin <3.0
  • Age less than 80 years old over 20 years old
  • Performance status (ECOG scale): 0-1
  • Adequate organ functions
  • Hb ≥7.0 g/dl
  • ANC ≥1,500/mm3
  • PLT ≥80,000/mm3
  • Liver function: AST/ALT ≤5×upper limit of normal
  • Creatinine ≤2.0 ULN

Exclusion criteria

  • Biopsy, drainage tube insertion, and other minor surgery
  • palliative surgery
  • Serious illness or medical conditions, as follows;
  • congestive heart failure (NYHA class III or IV)
  • unstable angina or myocardial infarction within the past 6 months,
  • significant arrhythmias requiring medication and conduction abnormality such as over 2nd degree AV block
  • uncontrolled hypertension
  • hepatic cirrhosis( ≥ Child class B)
  • interstitial pneumonia, pulmonary adenomatosis
  • psychiatric disorder that may interfere with and/or protocol compliance
  • unstable diabetes mellitus
  • uncontrolled ascites or pleural effusion
  • active infection
  • Pregnancy
  • Any patients judged by the investigator to be unfit to participate in the study

Treatment and study plan

nutritional support program

Dietary Supplement

Nutritional support program is briefly described below.

Interval: 5-10 days Contents: admission is required

  • Calories: 30-35Kg, via enteral or parenteral
  • Protein: 1.2-1.5g/Kg
  • Lipid : 1-1.5g/Kg
  • Mineral and vitamins supply
  • Blood glucose control
  • Daily monitoring by dietician and specialized nurse

Primary outcomes

  1. postoperative complication

    Time frame: at discharge. (expected the duration of hospital stay of postoperation is 4~6 weeks.)

    expected the duration of hospital stay of postoperation is 4~6 weeks.

Secondary outcomes

  1. postoperative hospital stay

    Time frame: expected the duration of hospital stay of postoperation is 4~6 weeks.

    expected the duration of hospital stay of postoperation is 4~6 weeks.

  2. quality of life

    Time frame: preoperative, postoperative 14days

    preoperative, postoperative 14days

  3. postoperative cost( + nutritional support cost)

    Time frame: at discharge. (expected the duration of hospital stay of postoperation is 4~6 weeks.)

    expected the duration of hospital stay of postoperation is 4~6 weeks.

Other outcomes

  1. immunologic change(CD4/CD8) after nutritional support

    Time frame: preoperative, postoperative 14days

    CD4/CD8, immunoglobulin G, M, A

Sponsors and collaborators

Lead sponsor

National Cancer Center, Korea

Other Gov

Collaborators

  • Fresenius Kabi

Registry information

Official study title

Prospective Study of Preoperative Nutritional Support in Malnutritional Pancreatobiliary Cancer Patients

Important dates

Study start
2013
Primary completion
2013
Study completion
2017
First posted
Dec 10, 2015
Registry last updated
Jun 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.